Restricted accessResearch articleFirst published online 2006-08
Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions
Pathomorphological studies described pathological heterogeneity in patients with multiple sclerosis (MS). Different effector mechanisms might therefore be responsible for lesion formation in MS. The present report shows that myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in common marmoset monkeys reflects one specific lesional subtype of MS, namely MS pattern II lesions with antibody/complement-mediated damage. MOG-induced EAE in marmoset monkeys will, therefore, provide an ideal model for therapeutic approaches directed against B-cell/antibody/complement in MS.
Lassmann H.Pathology of multiple sclerosis. In Compston A , Ebers G , Lassmann H , McDonald I , Matthews B , Wekerle H eds. McAlpine’s multiple sclerosis. Churchill Livingstone , 1998: 323-358.
2.
Lucchinetti C , Brück W , Parisi J , Scheithauer B , Rodriguez M , Lassmann H.A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases . Brain1999; 122: 2279-2295 .
3.
Kuhlmann T , Lingfeld G , Bitsch A , Schuchardt J , Brück W.Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time . Brain2002; 125: 2202-2212 .
4.
Lucchinetti C , Brück W , Parisi J , Scheithauer B , Rodriguez M , Lassmann H.Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination . Ann Neurol2000; 47: 707-717 .
5.
Massacesi L , Genain CP , Lee-Parritz D , Letvin NL , Canfield D , Hauser SL.Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis . Ann Neurol1995; 37: 519-530 .
6.
Brok HP , Bauer J , Jonker M , Blezer E , Amor S , Bontrop REet al.Non-human primate models of multiple sclerosis . Immunol Rev2001; 183: 173-185 .
7.
‘t Hart BA , Amor S.The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system . Curr Opin Neurol2003; 16: 375-383 .
8.
Villoslada P , Hauser SL , Bartke I , Unger J , Heald N , Rosenberg Det al.Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system . J Exp Med2000; 191: 1799-1806 .
9.
Adelmann M , Wood J , Benzel I , Fiori P , Lassmann H , Matthieu J-Met al.The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat . J Neuroimmunol1995; 63: 17-27 .
10.
Archelos JJ , Storch MK , Hartung H-P.The role of B cells and autoantibodies in multiple sclerosis . Ann Neurol2000; 47: 694-706 .
11.
Lucchinetti CF , Mandler RN , McGavern D , Brück W , Gleich G , Ransohoff RMet al.A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica . Brain2002; 125: 1450-1461 .
12.
Genain CP , Nguyen MH , Letvin NL , Pearl R , Davis RL , Adelman Met al.Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate . J Clin Invest1995; 96: 2966-2974 .
13.
Raine CS , Cannella B , Hauser SL , Genain CP.Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation . Ann Neurol1999; 46: 144-160 .
14.
Lucchinetti CF , Brück W , Rodriguez M , Lassmann H.Multiple sclerosis: lessons from neuropathology . Semin Neurol1998; 18: 337-349 .
15.
Von Budingen HC , Hauser SL , Ouallet JC , Tanuma N , Menge T , Genain CP.Frontline: epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination . Eur J Immunol2004; 34: 2072-2083 .
16.
Owens GP , Ritchie AM , Burgoon MP , Williamson RA , Corboy JR , Gilden DH.Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid . J Immunol2003; 171: 2725-2733 .
17.
Cepok S , Jacobsen M , Schock S , Omer B , Jaekel S , Böddeker Iet al.Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis . Brain2001; 124: 2169-2176 .
18.
Barnett MH , Prineas JW.Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion . Ann Neurol2004; 55: 458-468 .
19.
Keegan M , König F , McClelland R , Brück W , Morales Y , Bitsch Aet al.Humoral multiple sclerosis pathology correlates with response to therapeutic plasma exchange . Lancet2005; 360: 579-582 .
20.
Jordan EK , McFarland HI , Lewis BK , Tresser N , Gates MA , Johnson Met al.Serial MR imaging of experimental autoimmune encephalomyelitis induced by human white matter or by chimeric myelin-basic and proteolipid protein in the common marmoset . Am J Neuroradiol1999; 20: 965-976 .
21.
‘t Hart BA , Bauer J , Muller H-J , Melchers B , Nicolay K , Brok Het al.Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis . Am J Pathol1998; 153: 649-663 .
22.
Keegan M , Pineda AA , McClelland RL , Darby CH , Rodriguez M , Weinshenker BG.Plasma exchange for severe attacks of CNS demyelination: predictors of response . Neurology2002; 58: 143-146 .
23.
Brück W , Neubert K , Berger T , Weber JR.Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination-possible markers for an antibody-mediated process . Mult Scler2001; 7: 173-177 .
